Cargando…
Hiding the road signs that lead to tumor immunity
Tumors exploit many strategies to evade T cell–mediated destruction. For example, tumors can prevent T cell infiltration by modifying gene expression in the endothelial cells and pericytes that form their vasculature. New work showing that the T cell–attracting chemokine CCL2 can be posttranslationa...
Autores principales: | Schaer, David A., Lesokhin, Alexander M., Wolchok, Jedd D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182053/ https://www.ncbi.nlm.nih.gov/pubmed/21948803 http://dx.doi.org/10.1084/jem.20111856 |
Ejemplares similares
-
Hide and seek: the secret identity of the phosphatidylserine receptor
por: Williamson, Patrick, et al.
Publicado: (2004) -
Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
por: Holmgaard, Rikke B., et al.
Publicado: (2016) -
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014) -
Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013) -
Immune modulation for cancer therapy
por: Naidoo, J, et al.
Publicado: (2014)